Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Chemico-Biological Interactions|September 26, 2022
Elevated CDK5R1 expression associated with poor prognosis, proliferation, and drug resistance in colorectal and breast malignancies: CDK5R1 as an oncogene in cancersShaghayegh Dastjerdi, Amin Haghparast, Jalal Mosayebi Amroabadi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 23, 2023
Carcinogenic roles of MAFG-AS1 in human cancersMohsen Ahmadi, Firouzeh Morshedzadeh, Sayyed Mohammad Hossein Ghaderian, et al.
Molecular Genetics & Genomic Medicine|October 31, 2020
Upregulation of miR-9 and miR-193b over human Th17 cell differentiationFahimeh Shirani, Masoud Baghi, Mahsa Rostamian Delavar, et al.
Pathology, Research and Practice|December 21, 2023
Pathological roles of miRNAs and pseudogene-derived lncRNAs in human cancers, and their comparison as prognosis/diagnosis biomarkersBahareh Karimi, Khatere Mokhtari, Hossein Rozbahani, et al.
Journal of Materials Chemistry. B|May 15, 2025
Functionalized 3D-printed scaffolds for enhanced osteogenesis and guided bone regenerationMohammad Hosseini Hooshiar, Negin Ostadsharifmemar, Tohid Javaheri, et al.
The Journal of Biological Chemistry|November 7, 2025
Upregulation of miR-361-5p attenuates MPP+-induced neurotoxicity in dopaminergic SH-SY5Y cells as Parkinson's disease modelShiva Vaheb Hosseinabadi, Hananeh Tahamtan, Maryam Mahmoudian Esfahani, et al.
Molecular Biotechnology|June 3, 2023
An Update on the Application of CRISPR Technology in Clinical PracticeFirouzeh Morshedzadeh, Mahmoud Ghanei, Malihe Lotfi, et al.
Journal of Cellular and Molecular Medicine|May 21, 2021
MiR-193b deregulation is associated with Parkinson's diseaseMasoud Baghi, Elaheh Yadegari, Mahsa Rostamian Delavar, et al.
Pageof 10